BioMed Research International · 2014 · 30 citations · 26 references
Veterinary MedicineImmunologyMicrobiologyImmunizationImmunology Of Infectious DiseasesVaccinologyAdjuvant DesignRecombinant Protein VaccinesSubunit VaccinesVaccinationVaccine Antigen DiscoveryVaccine DeliveryAdjuvants For Subunit VaccinesLeptospirosis VaccinesPolysaccharide VaccinesProtein Subunit Vaccine FormulationsPurification Of Vaccine AntigensSubunit Vaccine Antigen DiscoverySubunit Vaccine ImmunogenicitySubunit Vaccine Production
Leptospiral immunoglobulin-like (Lig) proteins are of great interest due to their ability to act as mediators of pathogenesis, serodiagnostic antigens, and immunogens. Purified recombinant LigA protein is the most promising subunit vaccine candidate against leptospirosis reported to date, however, as purified proteins are weak immunogens the use of a potent adjuvant is essential for the success of LigA as a subunit vaccine. In the present study, we compared xanthan pv. pruni (strain 106), aluminium hydroxide (alhydrogel), and CpG ODN as adjuvants in a LigA subunit vaccine preparation. Xanthan gum is a high molecular weight extracellular polysaccharide produced by fermentation of Xanthomonas spp., a plant-pathogenic bacterium genus. Preparations containing xanthan induced a strong antibody response comparable to that observed when alhydrogel was used. Upon challenge with a virulent strain of L. interrogans serovar Copenhageni, significant protection (Fisher test, P < 0.05) was observed in 100%, 100%, and 67% of hamsters immunized with rLigANI-xanthan, LigA-CpG-xanthan, and rLigANI-alhydrogel, respectively. Furthermore, xanthan did not cause cytotoxicity in Chinese hamster ovary (CHO) cells in vitro. The use of xanthan as an adjuvant is a novel alternative for enhancing the immunogenicity of vaccines against leptospirosis and possibly against other pathogens.
26
Drug Development and Industrial Pharmacy
C. T. Rhodes · Drug Development and Industrial Pharmacy · 1995 · 1.3K citations
Control of B-cell responses by Toll-like receptors
Chandrashekhar Pasare, Ruslan Medzhitov · Nature · 2005 · 740 citations
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Chandrashekhar Pasare, Ruslan Medzhitov · Immunity · 2004 · 380 citations · Full text
Éverton F. Silva, Marco Alberto Medeiros, Alan J. A. McBride et al. · Vaccine · 2007 · 191 citations · Full text